Date published: 2026-6-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBL18 Inhibitors

FBL18, also known as F-box/LRR-repeat protein 18, is a protein encoded by the FBL18 gene. It belongs to the F-box family, which plays a crucial role in mediating protein degradation through the ubiquitin-proteasome system (UPS). Specifically, FBL18 acts as a substrate recognition component of the SCF (Skp1-Cullin-F-box) E3 ubiquitin ligase complex. This complex targets specific proteins for ubiquitination and subsequent degradation, thereby regulating various cellular processes such as cell cycle progression, signal transduction, and protein homeostasis. Inhibition of FBL18 can have significant implications for cellular functions due to its role in protein degradation. One mechanism of inhibition involves disrupting the formation or function of the SCF E3 ubiquitin ligase complex, thereby preventing the ubiquitination and degradation of target proteins. Additionally, inhibition of FBL18 may lead to the accumulation of specific proteins that are normally targeted for degradation by the UPS, resulting in dysregulation of signaling pathways and cellular processes. Moreover, since FBL18 is involved in diverse cellular functions, its inhibition may impact various physiological processes, including cell proliferation, differentiation, and apoptosis. Understanding the mechanisms of FBL18 inhibition is crucial for elucidating its role in cellular physiology and exploring strategies for conditions associated with dysregulated protein degradation pathways.

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$31.00
$128.00
$454.00
45
(1)

SB202190 is a selective inhibitor of p38 MAPK, a key kinase in the MAPK signaling pathway. Inhibition of p38 MAPK by SB202190 leads to the suppression of downstream signaling events that regulate FBL18 expression, resulting in its down-regulation.

Selumetinib

606143-52-6sc-364613
sc-364613A
sc-364613B
sc-364613C
sc-364613D
5 mg
10 mg
100 mg
500 mg
1 g
$29.00
$82.00
$420.00
$1897.00
$3021.00
5
(1)

Selumetinib (AZD6244) is a potent and selective inhibitor of MEK1 and MEK2, critical kinases in the MAPK/ERK signaling pathway. Inhibition of MEK1/2 by AZD6244 disrupts downstream signaling cascades that control FBL18 expression, leading to its down-regulation.